Entigen Closes Sydney Office, Lays off Australian Staff as Funding Dries up | GenomeWeb

Less than a year after the merger between eBioinformatics and Empatheon created Entigen, the company has closed its Sydney, Australia, office and laid off all its employees in Australia.

As BioInform went to press last week, a source at Entigen confirmed that the Sydney office was closed last month, that all Australian employees were laid off, and that a “substantial number” of US employees were also let go.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.